REGN News and Press, Regeneron Pharmaceuticals Inc. From 02/02/24

Atlas Lithium Corporation (ATLX) is expected to report $-0.47 for Q4 2023 Capital Product Partners L.P. (CPLP) is expected to report $0.7 for Q4 2023 WisdomTree Inc. (WT) is expected to report $0.11 for Q4 2023 Mitsubishi Corporation (MSBHF) is expected to report for Q3 2024 C3is ...

TARRYTOWN, N.Y., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the European Medicines Agency (EMA) has accepted for review the Marketing Authorization Application (MAA) for linvoseltamab to treat adult patients with relapsed/refrac...

2024-02-01 11:33:16 ET More on Regeneron Pharmaceuticals Regeneron Pharmaceuticals Inc. (REGN) 42nd Annual JPMorgan Healthcare Conference - (Transcript) Why I Expect Regeneron To Keep Delivering For Investors In 2024 (Upgrade) Regeneron Pharmaceuticals Inc. (REGN) Am...

2024-01-31 15:47:11 ET More on 2seventy bio 2seventy bio: An Overload Of Troubles At This Small Pharma 2seventy bio, Inc. (TSVT) Q3 2023 Earnings Call Transcript 2seventy stock rises as Regeneron acquires R&D assets Bristol-Myers Squibb wins EU nod for ex...

2024-01-30 09:31:39 ET A Massachusetts-based %Biotech company is stealing the show so far during Tuesday’s premarket hours after it was announced that the company has agreed to sell its pipeline of investigational cell therapies to Regeneron pharmaceuticals Inc. (Nasdaq: REGN) fo...

2024-01-30 07:24:33 ET More on Regeneron Pharmaceuticals Regeneron Pharmaceuticals Inc. (REGN) 42nd Annual JPMorgan Healthcare Conference - (Transcript) Why I Expect Regeneron To Keep Delivering For Investors In 2024 (Upgrade) Regeneron Pharmaceuticals Inc. (REGN) Am...

TARRYTOWN, N.Y., Jan. 30, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the formation of Regeneron Cell Medicines based on an agreement with 2seventy bio, Inc. to acquire full development and commercialization rights to its pipeline of investigational nov...

2024-01-29 13:32:25 ET More on iShares MSCI ACWI ETF: ACWI: A Stellar End To 2023, Eyeing Early 2024 Election Year Risks Global economic growth set to weaken further this year, World Bank says Top Global Triple Momentum stocks - BofA Securities Seeking Alpha&...

2024-01-28 12:00:53 ET More on Amgen, Vertex Pharma, etc. Biotech And Pharma Diversification Pays Off Up 40%, 3%-Yielding Amgen Is Still One Of My Favorite Healthcare Stocks Vertex And Crispr: Second Casgevy Approval Pushes Revenue Potential Into Multi-Billion Dollar...

2024-01-28 08:00:00 ET As the calendar transitions from January to February, the upcoming week promises a flood of earnings reports from some of the world's largest companies by market capitalization. Among the noteworthy releases are anticipated updates from tech giants Microsoft ( ...